C
Clearside Biomedical
A biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases
About Clearside Biomedical
Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing and delivering innovative therapies to treat serious eye diseases. The company specializes in the suprachoroidal space (SCS) injection platform, which allows for precise drug delivery to the back of the eye, targeting the choroid and retina. This method helps in treating conditions that cause irreversible and debilitating visual impairments by compartmentalizing the drug away from nondiseased tissues, thereby enhancing efficacy and reducing side effects.
Read full description
Clearside's primary clients include healthcare providers, ophthalmologists, and patients suffering from retinal diseases. The company operates in the biopharmaceutical market, specifically targeting ocular conditions. Clearside's business model revolves around the development, clinical testing, and commercialization of its proprietary SCS injection platform and associated therapies. Revenue is generated through product sales, licensing agreements, and partnerships with other pharmaceutical companies.
Clearside's innovative approach aims to address unmet medical needs in ophthalmology, providing more effective and safer treatment options for patients. The company's pipeline includes therapies for various retinal diseases, including uveitis, diabetic macular edema, and age-related macular degeneration.
At a glance
- Founded
- 2012
- Headquarters
- Alpharetta, United States
- Listing
- IPO 2016
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning Clearside Biomedical.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Hatteras Venture Partners
GRA Venture Fund
Santen
RMI Partners
Mountain Group Partners
Series B and later5 investors entered at this stage
Rock Springs Capital
Aju IB Investment
Perceptive Advisors
Cormorant Asset Management
HealthCare Royalty
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Clearside Biomedical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Clearside Biomedical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.